The rationale that led to the composition of the tried-and-tested Gengigel® line takes account of average demand by consumers for a response to inflammatory problems affecting the oral mucosa, which constitute a chronic problem among a large percentage of the population. Gengigel® is a patented medical device containing high molecular weight hyaluronic acid obtained by a biotechnological process, which guarantees a high level of purity. Its formulation is designed to resemble that of the hyaluronic acid found in normal gum tissue.
The Gengigel® line has been widely clinically tested in order to build its efficacy and safety profile.
The information contained on this website is not intended for U.S. residents
©2022 Ricerfarma s.r.l. - VAT 12603470159 - REA MI 1572885 - Cap. Soc. € 115.000,00 i.v.
About cookies